Popular
BlogNEW
CompaniesNEW
Finance
Technology
Banking
Information Technology
Oil and Energy
Internet
Mining and Metals
Communications
Real Estate
Biotechnology
Automotive
Medical
Retail
Energy
23andMe Investor Presentation Deck slide image

23andMe Investor Presentation Deck

Experienced Clinical Development Leadership Jennifer Low, MD, PhD Head of Development Genentech LOXO ONCOLOGY Erivedge (vismodegib) Vitrakvi (larotrectinib) Zelboraf (vemurafenib) Cotellic (cobimetinib) Maike Schmidt, PhD Sr Group Head, Translational Sciences Genentech FivePríme Avastin (bevacizumab) Tecentriq (atezolizumab) Dylan Glatt, PhD Sr Clinical Pharmacologist, 23ME-00610 PTL GILEAD Jyseleca (filgotinib) Copyright © 2024 23and Me, Inc. 23and Me 20
View entire presentation

Product

HomeSearchAccount

Categories

Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations

Company

InsightsContactSupport

Legal

Terms of ServicePrivacy Policy

Connect

TwitterLinkedInInstagramYouTube